Pulsed-field ablation and ultra-high-resolution mapping are opening a new era in AT treatment
⚡ #EHRATopicWeek on Atrial Tachycardias
Catheter ablation has become the preferred treatment strategy for most symptomatic or recurrent ATs, while antiarrhythmic drug therapy often shows limited long-term efficacy.
📌 Key concepts from the latest evidence:
• Beta-blockers and calcium channel blockers remain important for rate control
• Catheter ablation is now first-line in many patients
• High-resolution electroanatomical mapping has transformed our understanding of AT circuits
• Entrainment and activation mapping remain essential tools for distinguishing focal vs reentrant mechanisms
• Pulsed-field ablation and ultra-high-resolution mapping are opening a new era in AT treatment
💡 Success in AT ablation depends on identifying the “critical isthmus” — the key region maintaining the arrhythmia — while durable bidirectional block is increasingly recognized as a crucial procedural endpoint.
Importantly, recurrence remains a major challenge, especially in patients with structural heart disease, prior AF ablation, or extensive atrial scarring
Find out more in the #EHRA_ESC Consensus document on Atrial Tachycardias 👉bit.ly/4wk5sBn
@escardio @EuropaceEiC
33
xuxiaoyong retweeted
PVI Vs PVI+PWI outcome in 338 patients with perAF at 12 mths presented at #ESC2022 @davidchieng @DrHariSugumar
xuxiaoyong retweeted
Great follow up study to STABLE-SR! Congrats to Yang Gang & Minglong Chen et al. More reasons why we fundamentally need a shift to mechanistic AF work, because AF is not, and will likely never be scar-VT. We need to keep searching. @jaccjournals jacc.org/doi/abs/10.1016/j.j… – at Phoenix, AZ



























